Toes-Zoutendijk, E, Arbyn, M, Auvinen, A, Baldwin, D, Castells, X, Decensi, A, Hofvind, S, Ivanus, U, Senore, C, Thorat, M, van der Aalst, C, Pinto, ACPN, Bracchiglione, J, Feliu, A, Zeeb, H, D'Souza, E, Ritchie, D, Espina, C, Carvalho, AL, Lansdorp-Vogelaar, I. European Code Against Cancer, 5th edition - organised cancer screening programmes. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70197. PMID:41542798. IF:4.500(Q2/3D).

Feliu, A, Anderson, AS, Bauld, L, Fernández, E, Leitzmann, M, Morris, S, Srour, B, Vardavas, C, Vlad, I, Vuik, S, Weijenberg, M, Alvarado-Villacorta, R, Canelo-Aybar, C, Zeeb, H, Schüz, J, D'Souza, E, Ritchie, D, Espina, C, Bakogianni, I, Riboli, E. European Code Against Cancer, 5th edition - tobacco and nicotine containing products, second-hand smoke, alcohol and cancer. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70177. PMID:41542791. IF:4.500(Q2/3D).

Thorat, MA, Arbyn, M, Baldwin, D, Castells, X, Hofvind, S, Ivanus, U, Senore, C, Toes-Zoutendijk, E, van der Aalst, C, Canelo-Aybar, C, Fernández-Sáenz, FK, Feliu, A, Zeeb, H, Carvalho, AL, D'Souza, E, Ritchie, D, Espina, C, Lansdorp-Vogelaar, I, Decensi, A. European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70158. PMID:41250966. IF:4.500(Q2/3D).

Leitzmann, MF, Bakogianni, I, Anderson, AS, Bauld, L, Fernandez, E, Morris, S, Srour, B, Vardavas, C, Vlad, I, Vuik, S, Weijenberg, M, Figuls, MR, Rigau, D, Feliu, A, Zeeb, H, Schüz, J, D'Souza, E, Ritchie, D, Espina, C, Riboli, E. European Code Against Cancer, 5th edition - diet, excess body weight, physical activity, sedentary behavior, breastfeeding, and cancer. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70201. PMID:41542809. IF:4.500(Q2/3D).

Lima, JP, Mbuagbaw, L, Prasad, M, Kumar, A, Wafeu, GS, Bonnet, R, Agoritsas, T, Li, SY, Liu, ZM, Alonso-Coello, P, Nishijuka, FA, Mirza, R, Silva, CM, Alshanketi, R, Alsahafi, I, Alnuaimi, A, Heen, AF, Schwartz, L, Guyatt, G. Determinants of treatment decisions in advanced dementia: a protocol for a cross-cultural mixed-methods study. BMJ Open. 2025; 15(12)DOI:10.1136/bmjopen-2025-105188. PMID:41475825. IF:2.300(Q2/3D).

de Oliveira, JSR, Fernandez, RS, Molina, MR, Pinto, ACPN, Rocha, CR, Ferreira, TM, Peres, SV. Patient safety risk associated with synchronous telehealth: A scoping review. PLoS One. 2025; 20(12)DOI:10.1371/journal.pone.0336992. PMID:41401191. IF:2.600(Q2/4D).

Miravitlles, M, Calle, M, Molina, J, Almagro, P, Gomez, JT, Trigueros, JA, Sánchez-Angarita, E, Cosio, BG, Casanova, C, López-Campos, JL, Riesco, JA, Simonet, P, Rigau, D, Iskakova, A, Sanz, MP, Sobradillo, P, Alcázar-Navarrete, B, Garin, N, Soler-Cataluña, JJ. Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.10.008. PMID:41198528. IF:9.200(Q1/1D).

Meza, N, Madrid, E, Urrútia, G, Clarke, M. Aligning research funding and the production of useful evidence to reduce research waste. Bmj Evidence-Based Medicine. 2025; 30(6)DOI:10.1136/bmjebm-2025-114324. PMID:41326283. IF:7.600(Q1/1D).